These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37986027)

  • 21. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017-2020.
    Lu CF; Cang XM; Liu WS; Wang LH; Huang HY; Sang SM; Wang XQ; Fang XX; Xu F
    Lipids Health Dis; 2023 Aug; 22(1):130. PubMed ID: 37568178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population.
    Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Tomita H; Sawada K; Nakaji S; Matsuzaka M; Torok NJ; Fukuda S
    Cytokine; 2020 Feb; 126():154927. PubMed ID: 31756645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.
    Alkhouri N; Tamimi TA; Yerian L; Lopez R; Zein NN; Feldstein AE
    Dig Dis Sci; 2010 Sep; 55(9):2644-50. PubMed ID: 19960252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between serum β-carotene-to-retinol ratio and severity of hepatic steatosis in non-alcoholic fatty liver disease in Japan: A cross-sectional study.
    Kimura M; Mikami K; Endo T; Matsuzaka M; Sawada N; Igarashi G; Iino C; Hasegawa T; Sawada K; Ando M; Tokuda I; Suganuma H; Matsumoto M; Nakaji S; Fukuda S
    Nutrition; 2020; 79-80():110984. PubMed ID: 32966920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study.
    Zou Y; Lan J; Zhong Y; Yang S; Zhang H; Xie G
    Lipids Health Dis; 2021 Oct; 20(1):139. PubMed ID: 34657611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
    Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
    Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free Triiodothyronine Is Associated With Hepatic Steatosis and Liver Stiffness in Euthyroid Chinese Adults With Non-Alcoholic Fatty Liver Disease.
    Guo W; Qin P; Li XN; Wu J; Lu J; Zhu WF; Diao QQ; Xu NZ; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():711956. PubMed ID: 34456869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease.
    Zou Y; Hu C; Kuang M; Chai Y
    BMC Gastroenterol; 2022 Mar; 22(1):134. PubMed ID: 35331166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran.
    Aghakhani L; Haghighat N; Amini M; Hosseini SV; Masoumi SJ
    Gastroenterol Res Pract; 2022; 2022():5980390. PubMed ID: 35178085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic Steatosis.
    McHenry S; Awad A; Kozlitina J; Stitziel NO; Davidson NO
    Dig Dis Sci; 2023 Aug; 68(8):3451-3457. PubMed ID: 37291473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real-time two-dimensional shear wave elastography: A randomized clinical trial.
    Soleimani D; Rezaie M; Rajabzadeh F; Gholizadeh Navashenaq J; Abbaspour M; Miryan M; Razmpour F; Ranjbar G; Rezvani R; Jarahi L; Hashemy SI; Goshayeshi L; Nematy M
    Phytother Res; 2021 Mar; 35(3):1669-1679. PubMed ID: 33166032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 34. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
    World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease.
    Chen J; Su Y; Su X; Luo F
    Diabetes Res Clin Pract; 2023 Jul; 201():110733. PubMed ID: 37245725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Nonalcoholic Fatty Liver Disease With Osteoporotic Fractures: A Cross-Sectional Retrospective Study of Chinese Individuals.
    Wang Y; Wen G; Zhou R; Zhong W; Lu S; Hu C; Chai Y
    Front Endocrinol (Lausanne); 2018; 9():408. PubMed ID: 30083134
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol.
    Wang X; Han Y; Liu Y; Hu H
    BMC Gastroenterol; 2022 Sep; 22(1):419. PubMed ID: 36104672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remnant cholesterol as a causal risk factor for ischemic heart disease.
    Varbo A; Benn M; Tybjærg-Hansen A; Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG
    J Am Coll Cardiol; 2013 Jan; 61(4):427-436. PubMed ID: 23265341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
    Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
    J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.